You just read:

Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO‑1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting

News provided by

Infinity Pharmaceuticals, Inc.

Nov 10, 2018, 06:02 ET